(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPHTHA FUTUR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OPHTHA FUTUR

ST13

US500000079201974

Class

5, 10, 42

Filing

79201974

Registration

5372133

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

07/12/2025

Trademark type

Combined

Nice classes

5, 10, 42

Filing date

09/01/2016

Registration date

01/09/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/26/2024

Last transaction

07/12/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

DE

Examiner

PARKS, KIMBERLY

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "OPHTHA" in green with a green curved band over the letter "O", followed by the wording "FUTUR" in black.

Holders and representatives

Holders

Pharmpur GmbH

Representatives

Paul D. Bianco Fleit Gibbons Gutman Bongini & Bianco PL

Technical classification

Nice Classes

Class 5Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicinein particular ophthalmologic preparations; ocular pharmaceuticalspharmaceuticals to support ophthalmic surgery

Class 10

Surgicalmedicaldental and veterinary apparatus and instruments for use in ophthalmic treatment and ophthalmic surgerycataract removal equipmentvitrectomy equipment and endoscopes; artificial limbs; artificial eyes; artificial teeth; orthopedic articlessilicone orthopedic devices for therapeutic usesilicone orthopedic implantspillows and compression pads for orthopedic useelastic bandages and plaster bandages for orthopedic purposessynthetic supportive bandages and orthopedic support bandages; suture materials

Class 42

Scientific and technological servicesscientific researchanalysistestingquality management building and product developmentin the field of treatment of eye diseases and ophthalmic surgery; research relating to technologyin particular chemical technological research; advisory services relating to technological research in the field of chemicalphysicalbiological and technological research for the development of ophthalmic drugs and medical devices; provision of information relating to technological research in the field of ophthalmic pharmaceuticalsmaterials and medical devices used in ophthalmology; technological services in the field of ophthalmologytechnological consultationtechnological informationproduct developmentdevelopment of manufacturing equipment used for ophthalmic drugs and products and advisory in the field of site planning for manufacturing of ophthalmic devices; chemical research; chemical research and analysis services; research on the subject of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; medical and pharmaceutical research and development; consultancy pertaining to pharmacologyin particular ophthalmology; conducting clinical trials for pharmaceutical products; product evaluations and product registrationreports and post market follow up of ophthalmic products in international marketsevaluations of scientific projects related to the ophthalmic industry services for assessing the efficiency of pharmaceuticalsplanning and management of quality relevant activities in the field of ophthalmic manufacturing; research and development for the pharmaceutical industry; providing information about the results of clinical trials for pharmaceutical products; information technology consultancy services for the pharmaceutical and healthcare industries; all aforementioned services particularly relating to ophthalmology and ophthalmologic preparations

Publications

History of USPTO decisions and trademark events.

31 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

07/11/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

06/24/2025

INPC

INVALIDATION PROCESSED

06/24/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

03/26/2025

C71T

CANCELLED SECTION 71

07/26/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/09/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/05/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/01/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/17/2018

FIMP

FINAL DISPOSITION PROCESSED

04/17/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/09/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

01/09/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/24/2017

PUBO

PUBLISHED FOR OPPOSITION

10/24/2017

GPNX

NOTIFICATION PROCESSED BY IB

10/21/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/04/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/04/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/04/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/12/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/07/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/07/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/07/2017

RFNT

REFUSAL PROCESSED BY IB

03/25/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/07/2017

RFRR

REFUSAL PROCESSED BY MPU

03/07/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/07/2017

CNRT

NON-FINAL ACTION WRITTEN

03/06/2017

MAFR

APPLICATION FILING RECEIPT MAILED

02/28/2017

DOCK

ASSIGNED TO EXAMINER

02/24/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/24/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/23/2017

Continuous trademark protection

Get notified about every new filing that threatens OPHTHA FUTUR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.